-
平臺編號：bio-68986
-
國際編號：CRL-2629?
-
細胞信息： Loucy
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
Loucy
年限：38 years adult
數(shù)量：大量
細胞類型：T淋巴細胞
是否是腫瘤細胞：0
物種來源：人
生長狀態(tài)：懸浮生長
ATCC Number：CRL-2629?
相關(guān)疾病：其他疾病
器官來源：外周血
運輸方式：凍存運輸
細胞形態(tài)：淋巴樣
規(guī)格：0.5mg Designations: Loucy
Depositors: ?H Ben-Bassat
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens deposited as human
Morphology:lymphoblast
Source: Organ: peripheral blood
Disease: T-cell acute lymphoblastic leukemia
Cell Type: T lymphocyte;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Isolation: Isolation date: November, 1987
Oncogene:p53 + overexpressed; (mutated, GTG --> ATG mutation at codon 272)
Antigen Expression:OKT3+, OKT4+, THB4+, J5 +/-, OKT6-, TdT-, and HLA-DR- [53286 ]
DNA Profile (STR):Amelogenin: X
CSF1PO: 11,12
D13S317: 11,13
D16S539: 11
D5S818: 12
D7S820: 9,10
THO1: 8,9.3
TPOX: 8,9
vWA: 16,17
Cytogenetic Analysis:45,X,5q-,t(16;20)(p12;q13) [53286 ]
Age: 38 years adult
Gender: female
Ethnicity: White
Comments:The Loucy cell line was established in 1987 from the peripheral blood of a patient with T-cell acute lymphoblastic leukemia (T-ALL) obtained two months prior to her death [53286 ]
This cell line may be of value in evaluating the role of t(16;20) in the etiology of T-ALL. It is important for genetic studies.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 3 to 5 X 10(5) viable cells/ml.
Interval: Maintain cultures at cell concentrations between 3 X 10(5) and 3 X 10(6) viable cells/ml.
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Doubling Time: 24 to 36 hrs
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 53286: Ben-Bassat H, et al. Establishment of a human T-acute lymphoblastic leukemia cell line with a (16;20) chromosome translocation. Cancer Genet. Cytogenet. 49: 241-248, 1990. PubMed: 2208060
53290: Prokocimer M, et al. P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrations. Leuk. Lymphoma 29: 607-611, 1998. PubMed: 9643574
數(shù)量：大量
細胞類型：T淋巴細胞
是否是腫瘤細胞：0
物種來源：人
生長狀態(tài)：懸浮生長
ATCC Number：CRL-2629?
相關(guān)疾病：其他疾病
器官來源：外周血
運輸方式：凍存運輸
細胞形態(tài)：淋巴樣
規(guī)格：0.5mg Designations: Loucy
Depositors: ?H Ben-Bassat
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens deposited as human
Morphology:lymphoblast
Source: Organ: peripheral blood
Disease: T-cell acute lymphoblastic leukemia
Cell Type: T lymphocyte;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Isolation: Isolation date: November, 1987
Oncogene:p53 + overexpressed; (mutated, GTG --> ATG mutation at codon 272)
Antigen Expression:OKT3+, OKT4+, THB4+, J5 +/-, OKT6-, TdT-, and HLA-DR- [53286 ]
DNA Profile (STR):Amelogenin: X
CSF1PO: 11,12
D13S317: 11,13
D16S539: 11
D5S818: 12
D7S820: 9,10
THO1: 8,9.3
TPOX: 8,9
vWA: 16,17
Cytogenetic Analysis:45,X,5q-,t(16;20)(p12;q13) [53286 ]
Age: 38 years adult
Gender: female
Ethnicity: White
Comments:The Loucy cell line was established in 1987 from the peripheral blood of a patient with T-cell acute lymphoblastic leukemia (T-ALL) obtained two months prior to her death [53286 ]
This cell line may be of value in evaluating the role of t(16;20) in the etiology of T-ALL. It is important for genetic studies.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 3 to 5 X 10(5) viable cells/ml.
Interval: Maintain cultures at cell concentrations between 3 X 10(5) and 3 X 10(6) viable cells/ml.
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Doubling Time: 24 to 36 hrs
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 53286: Ben-Bassat H, et al. Establishment of a human T-acute lymphoblastic leukemia cell line with a (16;20) chromosome translocation. Cancer Genet. Cytogenet. 49: 241-248, 1990. PubMed: 2208060
53290: Prokocimer M, et al. P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrations. Leuk. Lymphoma 29: 607-611, 1998. PubMed: 9643574
